Immunogenic composition against equine herpesvirus type 1
AssigneeResearch Corporation Technologies, Inc.
InventorDennis J. O'Callaghan
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a gene encoding an envelope glycoprotein of equine herpesvirus type 1 (EHV-1), the glycoprotein D (gD) gene, its gene product and antibodies directed against gD polypeptides. The envelope glycoproteins of herpesvirus are major targets of the immune response to herpesviral infection. Hence, an important aspect of this invention is directed towards a vaccine against EHV-1 and treatment of EHV-1 infection by anti-EHV-gD antibodies or antisera.
Claims14
An isolated peptide comprising a portion of the sequence of Equine Herpes Virus-1 gD, wherein the portion comprises the sequence of amino acids 80-98 of FIG. 2.
An isolated peptide comprising a portion of the sequence of Equine Herpes Virus-1 gD, wherein the portion comprises the sequence of amino acids 343-362 of FIG. 2.
An isolated polypeptide comprising amino acids 1-442 of the Equine Herpes Virus-1 gD polypeptide of FIG. 2.
An isolated polypeptide comprising amino acids 51-442 of the Equine Herpes Virus-1 gD polypeptide of FIG. 2.
An isolated polypeptide comprising amino acids 57-442 of the Equine Herpes Virus-1 gD polypeptide of FIG. 2.
An isolated polypeptide comprising amino acids 58-442 of the Equine Herpes Virus-1 gD polypeptide of FIG. 2.
An isolated polypeptide comprising amino acids 77-442 of the Equine Herpes Virus-1 gD polypeptide of FIG. 2.
Dependencies are inferred from the claim text.